Methanocarba cycloalkyl nucleoside analogues
    3.
    发明申请
    Methanocarba cycloalkyl nucleoside analogues 有权
    甲烷碳环环烷基核苷类似物

    公开(公告)号:US20060270629A1

    公开(公告)日:2006-11-30

    申请号:US11500860

    申请日:2006-08-08

    CPC分类号: C07D473/34

    摘要: The present invention provides novel nucleoside and nucleotide derivatives that are useful agonist or antagonists of P1 and P2 receptors. For example, the present invention provides a compound of formula A-M, wherein A is modified adenine or uracil and M is a constrained cycloalkyl group. The adenine or uracil is bonded to the constrained cycloalkyl group. The compounds of the present invention are useful in the treatment or prevention of various diseases including airway diseases (through A2B, A3, P2Y2 receptors), cancer (through A3, P2 receptors), cardiac arrhythmias (through A1 receptors), cardiac ischemia (through A1, A3 receptors), epilepsy (through A1, P2X receptors), and Huntington's Disease (through A2A receptors).

    摘要翻译: 本发明提供了新的核苷和核苷酸衍生物,其是P1和P2受体的有用的激动剂或拮抗剂。 例如,本发明提供式A-M的化合物,其中A是修饰的腺嘌呤或尿嘧啶,M是受限制的环烷基。 腺嘌呤或尿嘧啶与受限制的环烷基键合。 本发明的化合物可用于治疗或预防各种疾病,包括气道疾病(通过A 2B,A 3,P 2,N 2, 受体),癌症(通过Aβ3 P2受体),心律失常(通过A1受体),心脏缺血(通过A 3, >受体),癫痫(通过A1,P2X受体)和亨廷顿氏病(通过2A2受体)。